DOMS Industries (DOMS) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
19 Jun, 2026Executive summary
Achieved 24.1% year-over-year revenue growth in Q2 FY26, with significant increases in profitability and strong domestic volume growth.
Expanded product portfolio with new launches in mechanical pencils, baby hygiene, scholastic stationery, kits, combos, and office supplies.
Strengthened market presence domestically and internationally through robust distribution and strategic partnerships.
Unaudited standalone and consolidated financial results for Q2 and H1 FY26 were approved with no material misstatements noted by auditors.
Acquisitions included 51% of Super Treads Private Limited and increased stake in Pioneer Stationery Private Limited to 57.5%.
Financial highlights
Q2 FY26 consolidated operating revenue: ₹567.9 Cr (₹56,677.12 lakhs), up 24.1% year-over-year; H1 FY26 revenue at ₹1,130.2 Cr, up 25.2%.
Q2 FY26 EBITDA: ₹99.5 Cr (margin 17.5%), up 15.8% year-over-year; PAT: ₹60.9 Cr (margin 10.7%), up 13.4%.
Standalone EPS for Q2 FY26 was ₹9.19 (basic), up from ₹7.92 year-over-year; consolidated EPS was ₹9.60 (basic), up from ₹8.84.
CapEx for H1 FY26: ~INR 150 crores; full-year CapEx guidance: INR 210–225 crores.
Total assets (consolidated) as of September 30, 2025, stood at ₹1,60,468.89 lakhs, with equity of ₹1,18,352.64 lakhs.
Outlook and guidance
Maintains full-year revenue growth guidance of 18–20%, with H2 growth expected to normalize as prior year base includes full Uniclan consolidation.
EBITDA margin guidance remains at 16.5–17.5% for ongoing and new capacity.
GST 2.0 reforms expected to boost long-term demand and market growth despite short-term disruptions.
Ongoing capacity expansion and modernization to support future growth, with major capacity-driven growth from Q2 FY27.
Results for the period are not fully comparable to prior periods due to recent acquisitions.
Latest events from DOMS Industries
- Q3 FY25 revenue and profit surged, supported by acquisitions, capacity expansion, and IPO funds.DOMS
Q3 24/2519 Jun 2026 - FY26 revenue up 21.6% YoY, EBITDA margin 17.3%, PAT up 12.2%, strong domestic demand.DOMS
Q4 25/2619 May 2026 - Q3 FY26 saw 18.2% revenue growth, 17.5% EBITDA margin, and strong expansion initiatives.DOMS
Q3 25/2617 Apr 2026 - Q1 FY25 saw strong revenue and profit growth, margin expansion, and strategic diversification.DOMS
Q1 24/252 Feb 2026 - Q2 FY25 revenue and profit rose sharply, aided by Uniclan acquisition and margin expansion.DOMS
Q2 24/2515 Jan 2026 - Q1 FY26 revenue rose 26.4% with strong margins, capacity expansion, and new product launches.DOMS
Q1 25/2623 Nov 2025 - Revenue and profit surged on new products, acquisitions, and capacity expansion.DOMS
Q4 24/2520 Nov 2025